$LOWLF
Lowell Farms Inc. Stock $lowlf

$lowlf Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424003785 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$4.874M	$7.495M	$28.27M
YoY Change	-35.24%	-19.3%	-35.08%
Cost Of Revenue	$5.701M	$14.28M	$35.71M
YoY Change	-22.9%	16.12%	-21.31%
Gross Profit	-$827.0K	-$6.789M	-$7.442M
YoY Change	-726.52%	125.32%	304.24%
Gross Profit Margin	-16.97%	-90.58%	-26.33%
Selling, General & Admin	$1.961M	$2.882M	$9.699M
YoY Change	-16.87%	-18.91%	-34.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$808.0K	$966.0K	$5.117M
YoY Change	-32.44%	-56.39%	-30.63%
% of Gross Profit
Operating Expenses	$2.059M	$2.986M	$10.12M
YoY Change	-16.47%	-16.64%	-33.75%
Operating Profit	-$2.886M	-$9.775M	-$17.56M
YoY Change	23.7%	48.22%	2.61%
Interest Expense	$9.000K	$567.0K	-$3.865M
YoY Change	-99.46%	-138.18%	-40.28%
% of Operating Profit
Other Income/Expense, Net	-$3.000K	$6.652M	$8.541M
YoY Change	-99.82%	3767.44%	-217.69%
Pretax Income	-$2.889M	-$13.06M	-$37.18M
YoY Change	-27.61%	17.13%	52.55%
Income Tax	$0.00	$1.000K	$161.0K
% Of Pretax Income
Net Earnings	-$2.889M	-$13.06M	-$37.34M
YoY Change	-28.49%	17.5%	52.02%
Net Earnings / Revenue	-59.27%	-174.24%	-132.11%
Basic Earnings Per Share	-$0.15		-$2.71
Diluted Earnings Per Share	-$0.15	-$0.70	-$2.71
COMMON SHARES
Basic Shares Outstanding	18.13M shares	18.13M shares	13.79M shares
Diluted Shares Outstanding	19.02M shares		13.79M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.175M	$2.311M	$2.311M
YoY Change	-9.2%	110.47%	110.47%
Cash & Equivalents	$1.175M	$2.311M	$2.311M
Short-Term Investments
Other Short-Term Assets	$2.253M	$2.397M	$2.397M
YoY Change	86.66%	57.49%	57.49%
Inventory	$4.224M	$4.760M	$4.760M
Prepaid Expenses
Receivables	$2.067M	$2.620M	$2.620M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.719M	$12.09M	$12.09M
YoY Change	-36.98%	-31.17%	-31.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.814M	$22.43M	$22.43M
YoY Change	-87.61%	-28.31%	-61.76%
Goodwill
YoY Change
Intangibles		$2.544M
YoY Change		5928.15%
Long-Term Investments
YoY Change
Other Assets	$465.0K	$555.0K	$555.0K
YoY Change	12.86%	34.38%	34.38%
Total Long-Term Assets	$24.63M	$25.53M	$25.53M
YoY Change	-75.04%	-74.79%	-74.79%
TOTAL ASSETS
Total Short-Term Assets	$9.719M	$12.09M	$12.09M
Total Long-Term Assets	$24.63M	$25.53M	$25.53M
Total Assets	$34.35M	$37.61M	$37.61M
YoY Change	-69.9%	-68.35%	-68.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.931M	$4.314M	$4.314M
YoY Change	14.21%	87.0%	87.0%
Accrued Expenses	$2.595M	$1.761M	$1.761M
YoY Change	500.69%	403.14%	-50.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.934M	$1.993M	$1.993M
YoY Change	-92.06%	-91.81%	-91.81%
Total Short-Term Liabilities	$8.570M	$8.613M	$8.613M
YoY Change	-73.04%	-71.9%	-71.9%
LONG-TERM LIABILITIES
Long-Term Debt	$17.16M	$17.52M	$17.52M
YoY Change	-55.04%	-56.26%	-56.26%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$17.16M	$17.52M	$17.52M
YoY Change	-55.04%	-56.26%	-56.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.570M	$8.613M	$8.613M
Total Long-Term Liabilities	$17.16M	$17.52M	$17.52M
Total Liabilities	$25.73M	$26.14M	$26.14M
YoY Change	-63.22%	-63.04%	-63.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.9M	-$181.0M
YoY Change	24.51%	26.0%
Common Stock	$192.5M	$192.4M
YoY Change	0.35%	0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.615M	$11.48M	$11.48M
YoY Change
Total Liabilities & Shareholders Equity	$34.35M	$37.61M	$37.61M
YoY Change	-69.9%	-68.35%	-68.35%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.889M	-$13.06M	-$37.34M
YoY Change	-28.49%	17.5%	52.02%
Depreciation, Depletion And Amortization	$808.0K	$966.0K	$5.117M
YoY Change	-32.44%	-56.39%	-30.63%
Cash From Operating Activities	-$1.025M	-$3.146M	-$6.041M
YoY Change	-212.39%	2320.0%	-6.25%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$77.00K	$135.0K
YoY Change	-100.0%	-94.21%	-96.82%
Acquisitions			$0.00
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$0.00	-$77.00K	-$135.0K
YoY Change	-100.0%	-94.03%	-96.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$111.0K	36.00K	7.389M
YoY Change	-83.84%	-104.65%	92.17%
NET CHANGE
Cash From Operating Activities	-$1.025M	-3.146M	-6.041M
Cash From Investing Activities	$0.00	-77.00K	-135.0K
Cash From Financing Activities	-$111.0K	36.00K	7.389M
Net Change In Cash	-$1.136M	-3.187M	1.213M
YoY Change	-679.59%	45.26%	-117.87%
FREE CASH FLOW
Cash From Operating Activities	-$1.025M	-$3.146M	-$6.041M
Capital Expenditures	$0.00	$77.00K	$135.0K
Free Cash Flow	-$1.025M	-$3.223M	-$6.176M
YoY Change	-216.08%	120.75%	-42.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1943000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	192445000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180967000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	11478000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	26135000	usd
CY2022	us-gaap	Revenues Revenues	43535000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3654000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8613000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	30650000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	3000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001838128
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2016Q1	lowlf	Changes In Adoption Accumulated Deficit ChangesInAdoptionAccumulatedDeficit	847000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	357000	usd
CY2022	lowlf	Due Date Of Commitment DueDateOfCommitment	2023
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56254
CY2023	dei	Entity Registrant Name EntityRegistrantName	LOWELL FARMS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	19 Quail Run Circle - Suite B
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Salinas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93907
CY2023	dei	City Area Code CityAreaCode	831
CY2023	dei	Local Phone Number LocalPhoneNumber	998-8214
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3069255	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18130566	shares
CY2023	dei	Auditor Firm AuditorFirmId	6580
CY2023	dei	Auditor Name AuditorName	GreenGrowth CPAs
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023	dei	Auditor Firm AuditorFirmId	6580
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	959000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1053000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	21398000	usd
CY2023Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	17522000	usd
CY2022Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	31340000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2023Q4	us-gaap	Participating Mortgage Loans Mortgage Obligations Amount ParticipatingMortgageLoansMortgageObligationsAmount	0	usd
CY2022Q4	us-gaap	Participating Mortgage Loans Mortgage Obligations Amount ParticipatingMortgageLoansMortgageObligationsAmount	8713000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	70706000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	191742000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-143625000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	48117000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37613000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118823000	usd
CY2023	us-gaap	Revenues Revenues	28265000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	35707000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45376000	usd
CY2023	us-gaap	Gross Profit GrossProfit	-7442000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-1841000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7302000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9553000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2397000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5274000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	421000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	448000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10120000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	15275000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-17562000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-17116000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8541000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2455000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-28000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-109000	usd
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-24295000	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-3240000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	3837000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	6363000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19619000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7257000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24373000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	161000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37342000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24564000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.71
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.71
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.17
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13790000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11318000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13790000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11318000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	70307000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24564000	usd
CY2022	lowlf	Shares Issued In Connection With Asset Acquisition Amount SharesIssuedInConnectionWithAssetAcquisitionAmount	1800000	usd
CY2022	lowlf	Share Re Purchase Amount ShareRePurchaseAmount	0	usd
CY2022	lowlf	Issuance Of Vested Rsus Amount IssuanceOfVestedRsusAmount	10000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	564000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	48117000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	48117000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37342000	usd
CY2023	lowlf	Shares Issued In Connection With Brand Sale Amount SharesIssuedInConnectionWithBrandSaleAmount	2027000	usd
CY2023	lowlf	Warrants Cancelled With Brand Sale Amount WarrantsCancelledWithBrandSaleAmount	-1555000	usd
CY2023	lowlf	Issuance Of Vested Rsus Amount IssuanceOfVestedRsusAmount	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	231000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	11478000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	37342000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	24564000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5117000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7376000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	712000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	937000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	231000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	564000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	616000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	517000	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-59000	usd
CY2023	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	3004000	usd
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0	usd
CY2023	lowlf	Gain Loss On Lease Settlement GainLossOnLeaseSettlement	880000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-28000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-109000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	24295000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3240000	usd
CY2023	lowlf	Gain On Lease Termination GainOnLeaseTermination	5020000	usd
CY2022	lowlf	Gain On Lease Termination GainOnLeaseTermination	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-927000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3542000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6019000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2564000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2731000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-454000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	270000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	106000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-443000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	242000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1136000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6041000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6444000	usd
CY2023	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	60000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4250000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	lowlf	Gain Loss On Lease Settlement GainLossOnLeaseSettlement	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-135000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4190000	usd
CY2023	lowlf	Issuance Costs Related To Subordinate Voting Share Offering IssuanceCostsRelatedToSubordinateVotingShareOffering	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	6552000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1527000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2497000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	75000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	210000	usd
CY2023	lowlf	Proceeds From Sale Leaseback ProceedsFromSaleLeaseback	8991000	usd
CY2022	lowlf	Proceeds From Sale Leaseback ProceedsFromSaleLeaseback	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	lowlf	Issuance Costs Related To Subordinate Voting Share Offering IssuanceCostsRelatedToSubordinateVotingShareOffering	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	lowlf	Issuance Of Subordinate Voting Shares To Acquire Purchase Rights IssuanceOfSubordinateVotingSharesToAcquirePurchaseRights	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7389000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3845000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1213000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6789000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1098000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7887000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2311000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1098000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3689000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4215000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	87000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	171000	usd
CY2023	lowlf	Purchase Of Property And Equipment Not Yet Paid PurchaseOfPropertyAndEquipmentNotYetPaid	7000	usd
CY2022	lowlf	Purchase Of Property And Equipment Not Yet Paid PurchaseOfPropertyAndEquipmentNotYetPaid	819000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	lowlf	Issuance Of Subordinate Voting Shares To Acquire Purchase Rights IssuanceOfSubordinateVotingSharesToAcquirePurchaseRights	1800000	usd
CY2023	lowlf	Issuance Of Subordinate Voting Shares In Convertible Debenture Repurchase IssuanceOfSubordinateVotingSharesInConvertibleDebentureRepurchase	2027000	usd
CY2022	lowlf	Issuance Of Subordinate Voting Shares In Convertible Debenture Repurchase IssuanceOfSubordinateVotingSharesInConvertibleDebentureRepurchase	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1974000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	360000	usd
CY2023	lowlf	Finite Lived Intangible Assets Remaining Amortization Period One FiniteLivedIntangibleAssetsRemainingAmortizationPeriodOne	P15Y
CY2023Q4	lowlf	Changes In Adoption Accumulated Deficit ChangesInAdoptionAccumulatedDeficit	847000	usd
CY2023	us-gaap	Revenue Recognition Services Licensing Fees RevenueRecognitionServicesLicensingFees	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.</p>
CY2022	us-gaap	Development Costs DevelopmentCosts	78000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1134000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	595000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	237000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	235000	usd
CY2023Q4	us-gaap	Supplies Supplies	26000	usd
CY2022Q4	us-gaap	Supplies Supplies	375000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	26000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	69000	usd
CY2023Q4	lowlf	Licenses And Payments LicensesAndPayments	106000	usd
CY2022Q4	lowlf	Licenses And Payments LicensesAndPayments	146000	usd
CY2023Q4	us-gaap	Advance Royalties AdvanceRoyalties	853000	usd
CY2022Q4	us-gaap	Advance Royalties AdvanceRoyalties	0	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	15000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	102000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2397000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1522000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1400000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7431000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	307000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	940000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3053000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2408000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4760000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10779000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	2607	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1780	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1492	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	948000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	558000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	17000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	287000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	158000	usd
CY2023Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	109000	usd
CY2022Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	921000	usd
CY2022Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	441000	usd
CY2023Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	441000	usd
CY2023Q4	lowlf	Equipment Purchase Accrual EquipmentPurchaseAccrual	0	usd
CY2022Q4	lowlf	Equipment Purchase Accrual EquipmentPurchaseAccrual	724000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	545000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	445000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1943000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3654000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	72651000	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	17203000	usd
CY2023	lowlf	Property Plant And Equipment Disposals1 PropertyPlantAndEquipmentDisposals1	15921000	usd
CY2023	lowlf	Property Plant And Equipment Remeasurements PropertyPlantAndEquipmentRemeasurements	4602000	usd
CY2023	us-gaap	Impairment Of Oil And Gas Properties ImpairmentOfOilAndGasProperties	-39688000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29643000	usd
CY2023	lowlf	Accumulated Depreciation Beginning AccumulatedDepreciationBeginning	14004000	usd
CY2023	us-gaap	Depreciation Depreciation	4711000	usd
CY2023	lowlf	Accumulated Amortization Disposals AccumulatedAmortizationDisposals	441000	usd
CY2023	lowlf	Accumulated Amortization Remeasurement AccumulatedAmortizationRemeasurement	2661000	usd
CY2023	lowlf	Accumulated Amortization Impairments AccumulatedAmortizationImpairments	8396000	usd
CY2023	lowlf	Accumulated Depreciation Ending AccumulatedDepreciationEnding	7217000	usd
CY2023Q4	lowlf	Net Books Value NetBooksValue	22426000	usd
CY2023	us-gaap	Depreciation Depreciation	4711000	usd
CY2022	us-gaap	Depreciation Depreciation	7022000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	8632000	usd
CY2023	lowlf	Impairment Expense ImpairmentExpense	8783000	usd
CY2022Q4	lowlf	Definite Lived Intangible Assets DefiniteLivedIntangibleAssets	42765000	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-37299000	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2050000	usd
CY2023Q4	lowlf	Definite Lived Intangible Assets DefiniteLivedIntangibleAssets	-3416000	usd
CY2022Q4	lowlf	Accumulated Amortization Beginning AccumulatedAmortizationBeginning	-563000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	406000	usd
CY2023	lowlf	Accumulated Amortization Impairment AccumulatedAmortizationImpairment	97000	usd
CY2023Q4	lowlf	Accumulated Amortization Ending AccumulatedAmortizationEnding	-872000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42202000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2544000	usd
CY2023	lowlf	Amortization Expense AmortizationExpense	406000	usd
CY2022	lowlf	Amortization Expense AmortizationExpense	354000	usd
CY2022	lowlf	Percentage Issued Outstanding Shares PercentageIssuedOutstandingShares	0.15	pure
CY2022	lowlf	Subordinate Voting Shares Issued SubordinateVotingSharesIssued	1000000	shares
CY2022	lowlf	Fair Value Of Shares FairValueOfShares	1800000	usd
CY2023Q4	lowlf	Aggregate Principal Amount AggregatePrincipalAmount	22157000	usd
CY2023Q4	lowlf	Purchase Of Warrants PurchaseOfWarrants	10627483000	usd
CY2023Q4	lowlf	Cancelled Common Shares CancelledCommonShares	4324845000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	13245000	usd
CY2023Q4	lowlf	Descriptions Of Royalty DescriptionsOfRoyalty	the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense
CY2022Q4	lowlf	Warrants Beginning Balance WarrantsBeginningBalance	17343000	shares
CY2023	lowlf	Warrants Issued In Conjunction With Convertible Debenture Offering WarrantsIssuedInConjunctionWithConvertibleDebentureOffering	-15052000	usd
CY2023	lowlf	Warrants Expired WarrantsExpired	-1165000	usd
CY2023Q4	lowlf	Warrants Ending Balance WarrantsEndingBalance	1126000	shares
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	21680000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8716000	usd
CY2023Q4	lowlf	Total Indebtness TotalIndebtness	3000	usd
CY2022Q4	lowlf	Total Indebtness TotalIndebtness	30396000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	759000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	3000	usd
CY2023	lowlf	Operating Lease Liability Beginning OperatingLeaseLiabilityBeginning	33999000	usd
CY2023	us-gaap	Sale Leaseback Transaction Rent Expense SaleLeasebackTransactionRentExpense	17068000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1970000	usd
CY2023	lowlf	Lease Remeasurement LeaseRemeasurement	-2064000	usd
CY2023	lowlf	Lease Settlement LeaseSettlement	-1202000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-26319000	usd
CY2023	lowlf	Operating Lease Remeasurement Classification OperatingLeaseRemeasurementClassification	0	usd
CY2023	lowlf	Operating Lease Liability Ending OperatingLeaseLiabilityEnding	19512000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	21423	usd
CY2023Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	26319	usd
CY2023	us-gaap	Other Expenses OtherExpenses	4896	usd
CY2023	us-gaap	Gain Loss On Sale Of Property GainLossOnSaleOfProperty	19400000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	3040000.00	usd
CY2023	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	1651000	usd
CY2022	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	3755000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1651000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2219000	usd
CY2023	lowlf	Total Components Of Lease Expense TotalComponentsOfLeaseExpense	3316000	usd
CY2022	lowlf	Total Components Of Lease Expense TotalComponentsOfLeaseExpense	5974000	usd
CY2023	lowlf	Amortization Of Leased Assets Operating Leases AmortizationOfLeasedAssetsOperatingLeases	1091	usd
CY2022	lowlf	Amortization Of Leased Assets Operating Leases AmortizationOfLeasedAssetsOperatingLeases	0	usd
CY2023	lowlf	Interest On Lease Liabilities Operating Leases InterestOnLeaseLiabilitiesOperatingLeases	1326	usd
CY2022	lowlf	Interest On Lease Liabilities Operating Leases InterestOnLeaseLiabilitiesOperatingLeases	0	usd
CY2023	lowlf	Operating Lease Amortization OperatingLeaseAmortization	2417	usd
CY2022	lowlf	Operating Lease Amortization OperatingLeaseAmortization	0	usd
CY2023	lowlf	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P8Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2021	lowlf	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P14Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3285000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3258000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3240000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3324000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	52341000	usd
CY2023Q4	lowlf	Total Lease Payments TotalLeasePayments	65448000	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	45936000	usd
CY2023Q4	lowlf	Total Future Lease Payments TotalFutureLeasePayments	19512000	usd
CY2023Q4	lowlf	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	13200000	shares
CY2023Q4	lowlf	Stock Option For Future Grant StockOptionForFutureGrant	3600000	shares
CY2023	lowlf	Vesting Period Descriptions VestingPeriodDescriptions	The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	231000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	564000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1007000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.7
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.6
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	828000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.3
CY2023	lowlf	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue	0	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	28000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.4
CY2023	lowlf	Aggregate Intrinsic Value Expired AggregateIntrinsicValueExpired	0	usd
CY2023	lowlf	Stock Options Cancelled StockOptionsCancelled	-354000	shares
CY2023	lowlf	Weighted Average Remaining Contactual Life Outstanding Beginning Balance WeightedAverageRemainingContactualLifeOutstandingBeginningBalance	P4Y7M6D
CY2023	lowlf	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1453000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.9
CY2023	lowlf	Weighted Average Remaining Contactual Life Outstanding Ending Balance WeightedAverageRemainingContactualLifeOutstandingEndingBalance	P5Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	lowlf	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisable	988000	shares
CY2023Q4	lowlf	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisable	2.09
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M12D
CY2023	lowlf	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodIntrinsicValue	0	usd
CY2023Q4	lowlf	Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvested And Expected SharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedAndExpected	1453000	shares
CY2023Q4	lowlf	Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaveragevested And Expected SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaveragevestedAndExpected	1.91
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2023	lowlf	Aggregate Intrinsic Value Vested And Expected AggregateIntrinsicValueVestedAndExpected	0	usd
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.30
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	191000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y11M26D
CY2023	lowlf	Rsus Outstanding Beginning Balance RsusOutstandingBeginningBalance	21000	shares
CY2023	lowlf	Weighted Average Fair Value Outstanding Beginning Balance WeightedAverageFairValueOutstandingBeginningBalance	1.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	17000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.02
CY2023	lowlf	Weighted Average Fair Value Outstanding Ending Balance WeightedAverageFairValueOutstandingEndingBalance	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	161000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.004	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008	pure
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	161000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	191000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	191000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	191000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1615000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1987000	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-3111000	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-15293000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4726000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17280000	usd
CY2023	lowlf	Valuation Allowance Deferred Tax Assets Change In Amount ValuationAllowanceDeferredTaxAssetsChangeInAmount	4726000	usd
CY2021	lowlf	Valuation Allowance Deferred Tax Assets Change In Amount ValuationAllowanceDeferredTaxAssetsChangeInAmount	17280000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	161000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23323000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17038000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	usd
CY2023Q4	lowlf	Deferred Tax Assets Tax Deferred Expense Depreciation DeferredTaxAssetsTaxDeferredExpenseDepreciation	0	usd
CY2022Q4	lowlf	Deferred Tax Assets Tax Deferred Expense Depreciation DeferredTaxAssetsTaxDeferredExpenseDepreciation	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23323000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17038000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	usd
CY2023Q4	lowlf	Deferred Tax Liabilities Share Based Compensation DeferredTaxLiabilitiesShareBasedCompensation	0	usd
CY2022Q4	lowlf	Deferred Tax Liabilities Share Based Compensation DeferredTaxLiabilitiesShareBasedCompensation	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	37342000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24677000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.71
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.71
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.17
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13790000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11318000	shares
CY2023	lowlf	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	13790000	shares
CY2022	lowlf	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	11318000	shares
CY2023	lowlf	Basic Shares BasicShares	13790000	shares
CY2022	lowlf	Basic Shares BasicShares	11318000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13790000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11318000	shares
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7302000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9553000	usd
CY2023	lowlf	Related Party Transaction Sales To Related Party RelatedPartyTransactionSalesToRelatedParty	487000	usd
CY2022	lowlf	Related Party Transaction Sales To Related Party RelatedPartyTransactionSalesToRelatedParty	274000	usd
CY2023	lowlf	Related Party Transaction Other Revenues From Transactions With Related Parties RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties	476000	usd
CY2022	lowlf	Related Party Transaction Other Revenues From Transactions With Related Parties RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties	223000	usd
CY2023	lowlf	Lease Term LeaseTerm	P12M
CY2023	lowlf	Total Payment TotalPayment	130000	usd
CY2022	lowlf	Total Payment TotalPayment	10000	usd

Files In Submission

Name	View Source	Status
0001654954-24-003785-index-headers.html	Edgar Link	pending
0001654954-24-003785-index.html	Edgar Link	pending
0001654954-24-003785.txt	Edgar Link	pending
0001654954-24-003785-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lowlf-20231231.xsd	Edgar Link	pending
lowlf-20231231_cal.xml	Edgar Link	unprocessable
lowlf_10k.htm	Edgar Link	pending
lowlf_10kimg4.jpg	Edgar Link	pending
lowlf_10kimg7.jpg	Edgar Link	pending
lowlf_ex311.htm	Edgar Link	pending
lowlf_ex312.htm	Edgar Link	pending
lowlf_ex321.htm	Edgar Link	pending
lowlf_ex322.htm	Edgar Link	pending
lowlf_ex41.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
lowlf-20231231_lab.xml	Edgar Link	unprocessable
lowlf-20231231_pre.xml	Edgar Link	unprocessable
lowlf_10k_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lowlf-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOWLF
Lowell Farms Inc. Stock $lowlf

2024 Q1 Form 10-K Financial Statement

#000165495424003785 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOWLF Lowell Farms Inc. Stock $lowlf

2024 Q1 Form 10-K Financial Statement

#000165495424003785 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOWLF
Lowell Farms Inc. Stock $lowlf